Queen Saenz + Schutz PLLC represented firm client Iodine Software (“Iodine”) in connection with a strategic growth investment from Advent International in a transaction that values Iodine at over $1 billion. Financial terms were not disclosed.
Iodine provides the leading clinical AI solution for highly accurate capture of patient documentation. Iodine’s platforms are trusted by more than 800 hospitals and are used by more than 80,000 healthcare providers nationwide.
More information on the transaction can be found here.